- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversy - Abstract
November 22, 2012
Frequency of brain metastases from prostate cancer: An 18-year single-institution experience - Abstract
November 22, 2012
Whole-body diffusion-weighted MRI compared with 18F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma - Abstract
November 22, 2012
Anastomotic leak after robot-assisted laparoscopic radical prostatectomy: Evaluation with MDCT cystography with multiplanar reformatting and 3D display - Abstract
November 21, 2012
The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms - Abstract
November 21, 2012
Changes in apparent diffusion coefficient and T(2) relaxation during radiotherapy for prostate cancer - Abstract
November 21, 2012
Interstitial brachytherapy in localized prostate cancer – update: Executive summary of final report N10-01, Version 1.0 - Abstract
November 21, 2012
Diabetes mellitus and prostate cancer risk in Asian countries: A meta-analysis - Abstract
November 21, 2012
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment - Abstract
November 20, 2012
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer - Abstract
November 20, 2012
The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer - Abstract
November 20, 2012
Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management - Abstract
November 20, 2012
Anti-angiogenic therapies in prostate cancer - Abstract
November 20, 2012